Quick Answer
Indaptus Therapeutics, Inc. reported Shares Outstanding of 2.17 million shares for fiscal year 2025.
Indaptus Therapeutics, Inc. Shares Outstanding — Annual History
| Fiscal Year | Shares Outstanding | YoY Change |
|---|---|---|
| 2025 | 2.17M | +258.3% |
| 2025 | 604,963 | +41.1% |
| 2024 | 428,799 | -94.9% |
| 2023 | 8.40M | +0.0% |
| 2022 | 8.40M | +1.7% |
| 2021 | 8.26M | +324.7% |
| 2020 | 1.94M | — |
Quarterly Shares Outstanding
| Quarter Ending | Shares Outstanding | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | 1.64M | -83.9% | +171.4% |
| June 30, 2025 | 604,963 | -92.9% | -96.2% |
| March 31, 2025 | 16.03M | +87.8% | +3639.4% |
| December 31, 2024 | 428,799 | -94.9% | -95.8% |
| September 30, 2024 | 10.20M | +21.4% | +19.2% |
| June 30, 2024 | 8.55M | +1.8% | +0.2% |
| March 31, 2024 | 8.54M | +1.6% | +1.6% |
| December 31, 2023 | 8.40M | +0.0% | +0.0% |
- Indaptus Therapeutics, Inc. showed an increase of +258.3% in Shares Outstanding compared to the prior fiscal year.
- Over the 2020–2025 period, Indaptus Therapeutics, Inc.’s shares outstanding has grown by 11.4% (from 1.94 million shares to 2.17 million shares).
- The most recent figure is from Indaptus Therapeutics, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 17, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: